reconstituted retatrutide Laboratory Reconstitution Bundle Retatrutide Research Peptide | GLP3-R

Retatrutide is a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, distinguishing it from approved agents such as semaglutide and tirzepatide

Distribute this across three to four meals for optimal muscle protein synthesis

The drug is designed to activate the glucagon receptor as part of a combined metabolic effect

On the kidneys, a pooled analysis of Phase 2 obesity and type 2 diabetes data showed reductions in the standard kidney-injury marker (the urine albumin-to-creatinine ratio, or UACR) of approximately 37% in adults with type 2 diabetes and 31.5% in adults with obesity but no type 2 diabetes, both on the 12 mg dose [12]